Citation Impact
Citing Papers
Chimeric antigen receptor -T cell therapy: Applications and challenges in treatment of allergy and asthma
2019
Cancer treatment and survivorship statistics, 2022
2022 Standout
Current and coming challenges in the management of the survivorship population
2020
A comprehensive map of molecular drug targets
2016 Standout
Disparities in cancer outcomes: Lessons learned from children with cancer
2011
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Prodrugs—from Serendipity to Rational Design
2011
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
Targeting apoptosis in cancer therapy
2020 Standout
MicroRNA biogenesis pathways in cancer
2015 Standout
Common variation at 6q16 within HACE1 and LIN28B influences susceptibility to neuroblastoma
2012
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
The 2020 WHO Classification of Soft Tissue Tumours: news and perspectives
2020 Standout
Potential Contribution of Cytochrome P450 2B6 to Hepatic 4-Hydroxycyclophosphamide Formation In Vitro and In Vivo
2011
Challenges and opportunities in childhood cancer drug development
2012
T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial
2014 Standout
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
Mechanisms of resistance to CAR T cell therapy
2019
Computational design of a synthetic PD-1 agonist
2021 StandoutNobel
Childhood and adolescent cancer statistics, 2014
2014 Standout
Reactivating TP53 signaling by the novel MDM2 inhibitor DS-3032b as a therapeutic option for high-risk neuroblastoma
2017
Cancer statistics, 2016
2016 Standout
Developing Drugs for Tissue‐Agnostic Indications: A Paradigm Shift in Leveraging Cancer Biology for Precision Medicine
2020
Dinutuximab
2016
The Future Is Now: Chimeric Antigen Receptors as New Targeted Therapies for Childhood Cancer
2012
Progress Born From a Legacy of Collaboration
2015
Ionizable Lipid Nanoparticles with Integrated Immune Checkpoint Inhibition for mRNA CAR T Cell Engineering
2023 StandoutNobel
Promising Therapeutic Targets in Neuroblastoma
2012
Cancer treatment and survivorship statistics, 2014
2014 Standout
Works of Navin Pinto being referenced
Racial and Ethnic Disparities in Risk and Survival in Children With Neuroblastoma: A Children's Oncology Group Study
2010
DRUG FOCUS: Pharmacogenetic Studies Related to Cyclophosphamide-Based Therapy
2009
Advances in Risk Classification and Treatment Strategies for Neuroblastoma
2015
Decreased Rates of Severe CRS Seen with Early Intervention Strategies for CD19 CAR-T Cell Toxicity Management
2016
Patterns of PD‐1, PD‐L1, and PD‐L2 expression in pediatric solid tumors
2017
Rationale and Design of the Targeted Agent and Profiling Utilization Registry Study
2018
Lymphocyte apheresis for chimeric antigen receptor T‐cell manufacturing in children and young adults with leukemia and neuroblastoma
2018
Using Germline Genomics to Individualize Pediatric Cancer Treatments
2012